Press Releases

Maiwald accompanies the acquisition of Pharmazeutische Fabrik Evers GmbH & Co. KG

Marco Stief, Partner, and Sebastian Haase, Senior Associate, have accompanied the acquisition of Pharmazeutische Fabrik Evers GmbH & Co. KG. The two attorneys-at-law from the Munich office of the law firm Maiwald were consulted due to their expertise regarding intellectual property and pharmaceutical law by the law firm Gütt Olk Feldhaus, which is specialized in M&A transactions.

Further information regarding the M&A transaction, wherein the law firm Kanzlei Gütt Olk Feldhaus represented Bright Future Pharmaceutical Laboratories Ltd. on the buy side can be found here.

About Maiwald

Maiwald is one of Germany’s largest and best-known firms in the field of intellectual property. Maiwald employs about 200 people working out of Munich and Düsseldorf and supporting clients in securing, defending and enforcing intellectual property rights. Clients include start-ups, medium-sized firms, and large corporations, across all industrial sectors. About 70 patent attorneys and attorneys-at-law advise and represent domestic and international clients in the following fields: pharma & healthcare, chemistry & materials, food & agriculture, electrical & mechanical engineering, communication & information technology, mobility & infrastructure, and medical technology & imaging. Maiwald’s team of patent attorneys and attorneys-at-law is highly experienced regarding patents & utility models, supplementary protection certificates, trademarks & designs, copyright, competition & antitrust law, contract law, employee invention law, and pharmaceutical law.

Maiwald at LinkedIn: https://www.linkedin.com/company/maiwald/

Press contact
Dr. Eva Dörner, Partner, Patentanwältin, European Patent Attorney
Maiwald Patentanwaltsgesellschaft mbH
Elisenhof, Elisenstraße 3
80335 München
T +49 (0)89 747 266 908
doerner.marketing@maiwald.eu

Eva Dörner at LinkedIn:
https://www.linkedin.com/in/eva-doerner-64b9b713b/

Newsletter